PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

PAR Broker Data, page-31

  1. 762 Posts.
    lightbulb Created with Sketch. 140
    No conviction in the buying today. I can't see much of a bounce until we get news.
    I wonder if this P3 trial readout delay is a subtle way of moving a few retail investors off the register and helping the instos who have more patience, get a buying opportunity.
    Something doesn't smell right.
    It looks about as clumsy as the capital raising this year.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.